Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025)
Burning Rock Biotech (BNR) posted quarterly Cash from Financing Activities of -$14000.0 for Q4 2025, down 40.0% year-over-year from -$23333.3 in Q4 2024, and down 105.02% on a QoQ basis from $279000.0 in Q2 2025.
Burning Rock Biotech (BNR) Cash from Financing Activities (2019 - 2025) Analysis & Trends
Burning Rock Biotech (BNR) has reported Cash from Financing Activities for 7 consecutive years, with -$14000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Financing Activities fell 40.0% year-over-year to -$14000.0; the TTM figure through Dec 2025 stood at $255279.1 (up 188.31% YoY), while the FY2025 annual figure was $272000.0, up 2820.0% from the prior year.
- Cash from Financing Activities came in at -$14000.0 for Q4 2025 at Burning Rock Biotech, down from $279000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $279000.0 in Q2 2025, with the low at -$12.5 million in Q4 2022.
- Average Cash from Financing Activities over 5 years is -$2.3 million, with a median of -$375000.0 recorded in 2022.
- Across the five-year window, Cash from Financing Activities slumped 1577.07% in 2023 and jumped 100.0% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at -$1.1 million in 2021, then tumbled by 1073.99% to -$12.5 million in 2022, then soared by 97.85% to -$269000.0 in 2023, then jumped by 96.28% to -$10000.0 in 2024, then tumbled by 40.0% to -$14000.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$14000.0, $279000.0, and -$10000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Burning Rock Biotech | 748.66 Mn | 683.48 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Jun 30, 2025 | 279,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | 279.06 |
| Sep 30, 2024 | 279.06 |
| Mar 31, 2024 | -10,348.62 |
| Mar 31, 2024 | -10,348.62 |
| Dec 31, 2023 | -269,000.00 |
| Dec 31, 2023 | -269,000.00 |
| Sep 30, 2023 | -6.29 Mn |
| Sep 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -138,000.00 |
| Jun 30, 2023 | -138,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | -12.50 Mn |
| Dec 31, 2022 | -12.50 Mn |